Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Douglas C Diruggiero , PA-C

Physician Assistant • Cartersville, GA

Active NPI 1730145327 Individual Practitioner Male Practitioner Accepts Medicare assignment
Practice location in NPPES

9 Medical Dr Ne
Cartersville, GA 301218003

Call 4702271600 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

9 Medical Dr Ne

Cartersville, GA 301218003

Telephone 4702271600
Fax 4702271606
Organization at the Same NPPES Address or Phone
Skin Cancer And Cosmetic Dermatology Center Pc Facility NPI 1144419458

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

CMS Doctors and Clinicians lists 1 group name: Skin Cancer And Cosmetic Dermatology Center Pc. See the list

Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File

Medical School

Duke University School Of Medicine

Graduation Year

1997

Medicare patients

703 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $139,378 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $99,208 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

1,043 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$761,086 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $366,354.35 across 591 records.

By nature of payment (3 largest of 6)

  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $210,936.00 across 119 records.
  • Consulting Fee: $89,667.34 across 49 records.
  • Travel and Lodging: $51,306.11 across 153 records.

Reporting-company totals (3 largest of 25)

  • Regeneron Pharmaceuticals, Inc.: $82,628.33 across 150 records.
  • Janssen Pharmaceuticals, Inc: $49,616.99 across 63 records.
  • Eli Lilly and Company: $41,589.93 across 57 records.

Research and ownership records are not included in these totals; they are in the table below.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

29 years (graduated 1997)

CMS Doctors and Clinicians data list 1997 as the year this clinician finished professional school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File.

NPI first issued

2006

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Douglas Diruggiero has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Douglas Diruggiero as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Cartersville and Georgia

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 95% of clinicians listed under Physician Assistant in Cartersville, GA (2024, 13 clinicians with data). Median for this group: 232. Middle half: 65 to 705.

More Medicare Part B services than 95% of clinicians listed under Physician Assistant in Georgia (2024, 2,111 clinicians with data). Median for this group: 206. Middle half: 69 to 679.

Medicare-allowed amount

A higher Medicare-allowed amount than 95% of clinicians listed under Physician Assistant in Cartersville, GA (2024, 13 clinicians with data). Median for this group: $11,402. Middle half: $6,417 to $45,086.

A higher Medicare-allowed amount than 95% of clinicians listed under Physician Assistant in Georgia (2024, 2,111 clinicians with data). Median for this group: $15,567. Middle half: $5,959 to $34,890.

Paid by Medicare

A higher Medicare payment amount than 95% of clinicians listed under Physician Assistant in Cartersville, GA (2024, 13 clinicians with data). Median for this group: $7,106. Middle half: $4,688 to $35,238.

A higher Medicare payment amount than 95% of clinicians listed under Physician Assistant in Georgia (2024, 2,111 clinicians with data). Median for this group: $11,516. Middle half: $4,485 to $25,995.

Medicare Part D prescriptions

Close to the middle for clinicians listed under Physician Assistant in Cartersville, GA (2024, 13 clinicians with data). Median for this group: 674. Middle half: 351 to 1,791.

More Part D prescriptions than 80% of clinicians listed under Physician Assistant in Georgia (2024, 2,084 clinicians with data). Median for this group: 227. Middle half: 71 to 699.

Part D drug cost

A higher Part D drug cost than 80% of clinicians listed under Physician Assistant in Cartersville, GA (2024, 13 clinicians with data). Median for this group: $107,228. Middle half: $31,934 to $229,039.

A higher Part D drug cost than 95% of clinicians listed under Physician Assistant in Georgia (2024, 2,084 clinicians with data). Median for this group: $4,172. Middle half: $609 to $75,033.

31 active clinicians are listed under Physician Assistant with a practice address in Cartersville, GA (4,665 in Georgia).

Addresses are self-reported to NPPES and may be out of date.

Telehealth indicator in Cartersville

12.9% of these 31 clinicians have the CMS telehealth indicator.

64.5% of these 31 clinicians are listed by CMS as accepting Medicare assignment.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 593 records totaling $373,419.85.

Manufacturer Payment Nature Product Type Amount ($)
Regeneron Pharmaceuticals, Inc.
General
In-kind items and services
DUPIXENT Research $6,431.00
Novartis Pharmaceuticals Corporation
Consulting Fee
Cash or cash equivalent
— General $5,400.00
Janssen Pharmaceuticals, Inc
Consulting Fee
Cash or cash equivalent
TREMFYA General $5,225.00
Janssen Pharmaceuticals, Inc
Consulting Fee
Cash or cash equivalent
— General $4,950.00
Sanofi and Genzyme US Companies
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
DUPIXENT General $4,363.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
DUPIXENT General $4,363.00
Arcutis Biotherapeutics, Inc.
Consulting Fee
Cash or cash equivalent
Zoryve General $4,275.00
Sanofi and Genzyme US Companies
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
In-kind items and services
— General $4,250.00
Sanofi and Genzyme US Companies
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
DUPIXENT General $4,188.00
Boehringer Ingelheim Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
SPEVIGO General $4,095.00
Eli Lilly and Company
Consulting Fee
Cash or cash equivalent
EBGLYSS General $4,050.00
Janssen Pharmaceuticals, Inc
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
TREMFYA General $3,850.00
Arcutis Biotherapeutics, Inc.
Consulting Fee
Cash or cash equivalent
Zoryve General $3,800.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
DUPIXENT General $3,665.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
DUPIXENT General $3,665.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
DUPIXENT General $3,665.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
DUPIXENT General $3,665.00
Sanofi and Genzyme US Companies
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
DUPIXENT General $3,665.00
Boehringer Ingelheim Pharmaceuticals, Inc.
Consulting Fee
Cash or cash equivalent
SPEVIGO General $3,600.00
UCB, Inc.
Consulting Fee
Cash or cash equivalent
Bimzelx General $3,420.00
Arcutis Biotherapeutics, Inc.
Consulting Fee
Cash or cash equivalent
Zoryve General $3,375.00
Boehringer Ingelheim Pharmaceuticals, Inc.
Consulting Fee
Cash or cash equivalent
SPEVIGO General $3,315.00
Eli Lilly and Company
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
EBGLYSS General $3,150.00
Eli Lilly and Company
Consulting Fee
Cash or cash equivalent
EBGLYSS General $3,150.00
Regeneron Pharmaceuticals, Inc.
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
— General $2,967.00

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
17003 Destruction of precancer skin growth, 2-14 growths
2,104 339 $6.96 $5.02
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
611 464 $91.27 $71.60
17000 Destruction of precancer skin growth, 1 growth
606 424 $82.30 $47.36
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
227 175 $134.50 $100.07
11102 Biopsy of related skin growth, first growth
152 138 $122.17 $75.70
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
143 132 $54.02 $44.47
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
143 25 $2.50 $0.96
96372 Injection of drug or substance under skin or into muscle
66 24 $31.09 $10.87
11103 Biopsy of related skin growth, each additional growth
39 30 $65.81 $38.59
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
35 35 $135.25 $88.83
17004 Destruction of precancer skin growth, 15 or more growths
33 28 $185.93 $127.39
17110 Destruction of skin growth, 1-14 growths
32 26 $135.38 $85.07
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
19 19 $206.57 $133.71
69100 Biopsy of ear
12 12 $124.24 $70.92

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Ketoconazole Ketoconazole 179 5,112 $3,109.28 108
Triamcinolone Acetonide Triamcinolone Acetonide 170 4,828 $1,689.47 145
Clobetasol Propionate Clobetasol Propionate 76 2,248 $2,949.93 54
Mupirocin Mupirocin 66 1,243 $662.74 53
Dupixent Pen Dupilumab 50 1,400 $188,809.71 —
Minocycline Hcl Minocycline Hcl 39 958 $995.51 28
Minoxidil Minoxidil 35 1,545 $222.23 —
Fluorouracil Fluorouracil 35 882 $2,417.38 31
Metronidazole Metronidazole 34 1,112 $1,568.18 25
Ciclopirox Ciclopirox Olamine 29 932 $608.94 22
Clindamycin Phosphate Clindamycin Phosphate 23 669 $688.06 20
Ciclopirox Ciclopirox 22 553 $604.58 16
Hydrocortisone Hydrocortisone 18 321 $129.11 16
Mometasone Furoate Mometasone Furoate 17 426 $305.18 14
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim 16 167 $62.64 16
Imiquimod Imiquimod 15 385 $313.75 —
Cosentyx Unoready Pen Secukinumab 15 512 $166,685.95 —
Valacyclovir Valacyclovir Hcl 14 204 $395.54 11
Terbinafine Hcl Terbinafine Hcl 14 575 $79.89 —
Betamethasone Dipropionate Betamethasone Dipropionate 12 308 $636.91 —
Tacrolimus Tacrolimus 12 262 $1,308.21 11
Cosentyx Sensoready Pen Secukinumab 12 336 $89,636.76 —
Bimzelx Autoinjector Bimekizumab-Bkzx 12 336 $172,372.56 —
Prednisone Prednisone 11 315 $51.89 —
Otezla Apremilast 11 330 $50,692.22 —

(top 25 shown)

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Self-certified to NPPES: 2020-04-29
Physician Assistant Primary Specialty

NUCC Taxonomy Code: 363A00000X

License # reported to NPPES GA 003061

A physician assistant is a person who has successfully completed an accredited education program for physician assistant, is licensed by the state and is practicing within the scope of that license. Physician assistants are formally trained to perform many of the routine, time-consuming tasks a physician can do. In some states, they may prescribe medications. They take medical histories, perform physical exams, order lab tests and x-rays, and give inoculations. Most states require that they work under the supervision of a physician.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Georgia Composite Medical Board.
Look Up on State Board Site

Additional State Medicaid & Healthcare Payer Identifiers

Medicaid ID
534385262L (GA)
Medicaid ID
534385262C (GA)

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - PHYSICIAN ASSISTANT

Medicare Enrollment ID

I20050215000209

Enrollment State Jurisdiction

GA

PECOS Control ID

2860444114

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File

Skin Cancer And Cosmetic Dermatology Center Pc

10 Medical Dr Ne, Rome, GA 301614912

Phone: 7063782235

Skin Cancer And Cosmetic Dermatology Center Pc

1107 Memorial Dr, Dalton, GA 307208662

Phone: 7062777311

Skin Cancer And Cosmetic Dermatology Center Pc

420 E 2nd Ave, Rome, GA 301613210

Phone: 7063782235

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

1 listed
Jodi-Ann Moore , PA

Physician Assistant

NPI 1962658963

Physician Assistant

Career & Practice History Timeline

Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status

11 Historical Events
âś…
NPI Profile Active January 02, 2018

NPI status registered as active in NPPES database

📍
Updated Practice Location January 02, 2018

Registered at 9 MEDICAL DR NE, CARTERSVILLE, GA 301218003 (Tel: 4702271600)

📍
Updated Business Mailing Address January 02, 2018

Registered at 136 BATTLEFIELD CROSSING CT, RINGGOLD, GA 307365176 (Tel: 7062777311)

👤
Provider Name / Credentials Updated January 02, 2018

Recorded as DOUGLAS DIRUGGIERO, PAC

🎓
Medical Taxonomy / Specialty Registered (Primary Specialty) January 02, 2018

Physician Assistant (license number reported to NPPES: GA 003061)

âś…
NPI Profile Active October 01, 2015

NPI status registered as active in NPPES database

📍
Practice Location (Initial Record) October 01, 2015

Registered at 1253 MONTAUK HIGHWAY, WEST ISLIP, NY 117954916 (Tel: 6316653376)

📍
Business Mailing Address (Initial Record) October 01, 2015

Registered at 1253 MONTAUK HIGHWAY, WEST ISLIP, NY 117954916 (Tel: 6316653376)

👤
Provider Name / Credentials (Initial Record) October 01, 2015

Recorded as DOUGLAS DIRUGGIERO, PAC

🎓
Medical Taxonomy / Specialty Registered (Primary Specialty) October 01, 2015

Physician Assistant (license number reported to NPPES: GA 003061)

🟢
Initial NPI Registration & Enumeration April 24, 2006

First registered as active Individual Practitioner in NPPES Database.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1730145327
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: April 24, 2006
Last Update: November 27, 2023
Sole Proprietor: No

Other Physician Assistants in Cartersville

All Physician Assistants in Cartersville

Mailing Address

136 Battlefield Crossing Ct

Ringgold, GA 307365176

Phone: 7062777311

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.